BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:Returning for its 11th year\, the IMPACCT: Real World Evidence Summit 2023 will deep dive into the use of RWE for regulatory submission s and clinical trial innovation to unlock unstructured healthcare data an d transform disease treatment.\n\nFollowing exciting FDA and EMA changes\ , this comprehensive industry-led forum addresses how drug developers can leverage RWE from the beginning to the end of a study\, ensuring clinica l studies are well-designed\, include appropriate protections for their p atients and upload data integrity.\n\nJoin 100+ senior leaders in RWE\, R WD\, real world analytics experts and epidemiologists from pharma and bio tech to take part in this three-day summit with over 18 hours of exclusiv e content.\n\nJoin your peers to learn how to leverage the new FDA extern al controls draft guidance to create synthetic control arms using RWE\, a s well as EHR data and artificial intelligence. Don't miss this unique op portunity to explore how to leverage RWE to target patient populations an d drive DE and I into trials.\n\nURLs:Brochure: \;https://go.evvnt.co m/1827330-2?pid=185Tickets: \;https://go.evvnt.com/1827330-3?pid=185\ n\nPrices:Drug Developer - Conference + Workshop Day: USD 4297.00\,Drug D eveloper - Conference Only: USD 2999.00\,Academic - Conference + Workshop Day: USD 3697.00\,Academic - Conference Only: USD 2599.00\,Service Provi der - Conference + Workshop Day: USD 5297.00\,Service Provider - Conferen ce Only: USD 3799.00\n\nSpeakers: \;Akshay Vashist\, Head of Medical and Real World Data Analytics\, Otsuka\, Alexander Cole\, Executive Direc tor and Global Head of Epidemiology and Real World Science\, Alexion Phar maceuticals\, Amit Kulkarni\, Head of Heath Economic Modelling and Decisi on Sciences\, Otsuka\, Angela Dobes\, SVP\, Crohn's and Colitis Foundatio n of America\, Aracelis Torres\, Senior Vice President\, Customer Solutio ns and Quantitative Sciences\, Verana Health\, Ashita Batavia\, Senior Di rector - Real-World Evidence\, Advanced Analytics Portfolio\, Oncology Re search and Development\, Janssen\, Charles Makin\, Head Of Global Health Economics \,Outcomes research\, Value Access and Pipeline Franchise\, Bio gen\, Danielle Bargo\, Director\, RWE and US HEOR Lead\, Eisai US\, Gina Valo\, Vice President of Clinical Research Products\, Verity Health Syste m\, Jeff Wessinger\, Vice President and General Manager\, Life Sciences\, PointClickCare\, Jesper Kjær\, Director of Data Analytics Centre\, Danis h Medicines Agency\, Kelly Zou\, Head of Global Medical Analytics and Rea l World Evidence\, Viatris Inc.\, Lina Titievsky\, Senior Director and He ad of Immunology and Opportunistic Epidemiology\, GlaxoSmithKline Plc\, M egan O'Brien\, Associate Vice President\, CORE\, Merck and Co\, Rob Kales nik-Orszulak\, Senior Director\, Global Regulatory Strategy\, Bristol Mye rs Squibb\, Robertino Mera-Giler\, Head of Biostatistics\, Epidemiology a nd Machine Learning\, Freenome Inc.\, Stephanie Watkins\, Senior Director - Real World Evidence Inflammation\, Gilead Sciences\, Stuart Turner\, H ead of Real World Analytics and Innovation\, Rocket Pharmaceuticals Ltd.\ , Sunday Clark\, Director - Real-World Evidence Scientist\, Pfizer\, Vand ana Ayyar\, Gupta Scientific Advisor\, National Institute for Health and Clinical Excellence - NICE\, William Blumentals\, Head of Pharmacoepidemi ology\, Specialty Care\, Sanofi Genzyme\n\nTime: \;8:00 am to 5:00 pm \n DTEND:20231025T170000 DTSTAMP:20260512T214301Z DTSTART:20231023T080000 LOCATION:Hilton Boston Logan Airport\, One\, Hotel Drive\, Boston\, Massac husetts\, 02128\, SEQUENCE:0 SUMMARY:Returning for its 11th year\, the IMPACCT: Real World Evidence Sum mit 2023 will deep dive into the use of RWE for regulatory submissions an d clinica... UID:f16021f3-e5c3-4841-82bd-65c3727712ba END:VEVENT END:VCALENDAR